CheckMate 204 Study

CheckMate 204 Study

moasc

7 months
24 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

John Fruehauf, MD of UC Irvine Health discusses new first-line therapy for asymptomatic melanoma brain metastases.

 

 

 

 

new first-line therapy, asymptomatic melanoma brain metastases, uc irvine health, checkmate 204 study, study, checkmate 204

Up Next Autoplay